Chemoinformaics analysis of 15-O-propionylbruceolide
| Molecular Weight | 494.493 | nRot | 3 |
| Heavy Atom Molecular Weight | 464.253 | nRig | 28 |
| Exact Molecular Weight | 494.179 | nRing | 5 |
| Solubility: LogS | -3.677 | nHRing | 2 |
| Solubility: LogP | 0.843 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 68.9058 |
| nHD | 3 | BPOL | 40.5122 |
| QED | 0.291 |
| Synth | 6.488 |
| Natural Product Likeliness | 3.355 |
| NR-PPAR-gamma | 0.709 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.997 |
| Pgp-sub | 0.765 |
| HIA | 0.796 |
| CACO-2 | -5.312 |
| MDCK | 0.0000763 |
| BBB | 0.69 |
| PPB | 0.438572 |
| VDSS | 0.39 |
| FU | 0.530322 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.767 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.691 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.044 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.11 |
| CYP3a4-inh | 0.163 |
| CYP3a4-sub | 0.262 |
| CL | 6.111 |
| T12 | 0.11 |
| hERG | 0.003 |
| Ames | 0.018 |
| ROA | 0.437 |
| SkinSen | 0.012 |
| Carcinogencity | 0.044 |
| EI | 0.006 |
| Respiratory | 0.063 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.760842 |